Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020

by NASDAQ Market News January 30, 2020

NASDAQ Market News
Click here to email author

Aprea Therapeutics Receives FDA Breakthrough Therapy Designation for APR-246 in Combination with Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) with a TP53 Mutation

Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020

Ads